Cargando…
Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
The consumption of immunoglobulins (Ig) is increasing due to better recognition of antibody deficiencies, an aging population, and new indications. This review aims to examine the various dosing regimens and research developments in the established and in some of the relevant off-label indications i...
Autores principales: | Kerr, Jacqueline, Quinti, Isabella, Eibl, Martha, Chapel, Helen, Späth, Peter J., Sewell, W. A. Carrock, Salama, Abdulgabar, van Schaik, Ivo N., Kuijpers, Taco W., Peter, Hans-Hartmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263903/ https://www.ncbi.nlm.nih.gov/pubmed/25566244 http://dx.doi.org/10.3389/fimmu.2014.00629 |
Ejemplares similares
-
On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events
por: Späth, Peter J., et al.
Publicado: (2015) -
Editorial: Immunoglobulin Therapy in the 21st Century – the Dark Side of the Moon
por: Farrugia, Albert, et al.
Publicado: (2015) -
Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014) -
An Increase in the Tobacco Age-of-Sale to 21: For Debate in Europe
por: Nuyts, Paulien A W, et al.
Publicado: (2019) -
Safety of Uncrossmatched ABO-Compatible RBCs in Alloimmunized Patients with Bleeding: Data from Two Decades: Results of a Systematic Analysis in 6,109 Patients
por: Ringel, Frauke, et al.
Publicado: (2021)